Van Den Born Simon sold 2,046 shares of Marex Group Ltd at $67.68 for −$138k on Nov 5, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
President
President
Filed Nov 9, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$138,468.17Shares × reported price
Shares traded
2,046Ordinary Shares
Price per share
$67.68Reported price. Read footnotes for ranges.
% of reported position traded
0.14%This security and ownership context
Holdings after
1,435,942Direct
Trade date
Nov 5, 2026Sell
Filed
Nov 9, 2026, 4:05 PM ET4-day reporting delay
Accession
0001193125-26-453555Code S · Transaction 395766
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,437,988 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 5, 2026Sell6,422$64.78−$415,999.82Trade 395763
Nov 5, 2026Sell6,215$65.81−$409,027.80Trade 395764
Nov 5, 2026Sell4,451$66.66−$296,719.24Trade 395765
Nov 5, 2026Sell3,101$68.70−$213,023.20Trade 395767
Nov 5, 2026Sell221$69.36−$15,329.53Trade 395768
6 transaction rows in this filing. Joint filers share the same rows.

MRX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MRX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 16, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +12%1w ago −1.7%1d ago +6.3%
Returns since7d30d90d180d1y

Footnotes in full

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026. F2: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $64.17 to $65.16 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $65.17 to $66.155 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F4: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $66.1725 to $67.165 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.2075 to $68.13 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F6: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.17 to $69.0375 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F7: The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.24 to $69.61 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F8: The number of ordinary shares reported herein includes 272,659 shares underlying unvested deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.